Article
Hydrogen Sulfide Deficiency and Therapeutic Targeting in Cardiometabolic HFpEF: Evidence for Synergistic Benefit with GLP-1/Glucagon Agonism
2024-09-19
Abstract excerpt
<h4>ABSTRACT</h4> <h4>Background</h4> Heart failure with preserved ejection fraction (HFpEF) is a significant public health concern with limited treatment options. Dysregulated nitric oxide-mediated signaling has been implicated in HFpEF pathophysiology, however, little is known about the role of endogenous hydrogen sulfide (H 2 S) in HFpEF. <h4>Objectives</h4> This study evaluated H 2 S bioavailability in p...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 97e7a205-b886-5af7-bd97-0a8f03565d56
- DOI
- 10.1101/2024.09.16.613349
